drugset

drugset / Trial / NCT00823693

Safety and Efficacy Study of Bimosiamose Cream to Treat Psoriasis

NCT00823693 ↗

Phase 2 Completed 107 enrolled Revotar Biopharmaceuticals AG

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine whether Bimosiamose Cream is safe and effective in the treatment of plaque type psoriasis.

Timeline

Start: —
Primary completion: —
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Bimosiamose	Small molecule	—	—

Indications